Pharmaceutical Industry Information Portal

Sun Pharma adds Uractiv™ portfolio in Romania, which brings in $8.7 million every year

Sun Pharmaceutical Industries, May 27th announced that one of its subsidiaries, S.C. Terapia S.A., Romania has acquired the Uractiv portfolio from Fiterman Pharma in Romania. The Uractiv portfolio comprises food supplements including minerals, vitamins and adjuvants; cosmetics and medical devices used for maintaining urinary tract health.

UractivTM is the No. 1 brand in its category in Romania, trusted by consumers for more than 10 years. The portfolio including 12 SKUs has annualised revenues of approximately US$ 8.7 million. The products cater to both adults and children.

Aalok Shanghvi, EVP & HeadGeneric R&D, Generic Global BD and Emerging Markets, Sun Pharma,said:

We are excited to add UractivTM to our consumer healthcare portfolio in Romania. This
acquisition is in line with our strategy to further expand our non-prescription product
basket in Romania and neighbouring markets. We have a strong presence in Romania with Terapia being the number one company in the generics and OTC market. We will leverage our robust marketing and distribution strengths to grow these brands further.

Since last year, the company’s share price has risen nearly 28.6%. The stock rose slightly on Friday.


Expert Articles